Suven Pharmaceuticals Limited (SUVENPHAR) — Strategic Asset Allocation Index
Suven Pharmaceuticals Limited (SUVENPHAR) has a Strategic Asset Allocation Index of 46.2% as of September 2022. Strategic assets (PP&E of Rs6.95 Billion plus long-term investments of Rs-) total Rs6.95 Billion, measured against net assets of Rs15.03 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Suven Pharmaceuticals Limited's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Suven Pharmaceuticals Limited Strategic Asset Allocation Index (2019–2022)
This chart shows how Suven Pharmaceuticals Limited's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of September 2022, the index stands at 46.2%, representing strategic assets of Rs6.95 Billion against net assets of Rs15.03 Billion INR. For live market cap and overall valuation, see market cap of Suven Pharmaceuticals Limited.
Annual Strategic Asset Allocation Index for Suven Pharmaceuticals Limited (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Suven Pharmaceuticals Limited from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Suven Pharmaceuticals Limited (SUVENPHAR) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (INR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 36.8% | Rs5.62 Billion | Rs5.62 Billion | Rs- | Rs15.27 Billion | ▼ -8.5 pp |
| 2021 | 45.3% | Rs5.35 Billion | Rs5.35 Billion | Rs- | Rs11.81 Billion | ▼ -8.6 pp |
| 2020 | 53.9% | Rs4.56 Billion | Rs4.56 Billion | Rs- | Rs8.45 Billion | ▼ -10.3 pp |
| 2019 | 64.3% | Rs3.79 Billion | Rs3.79 Billion | Rs- | Rs5.90 Billion | — |